APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhaled NO Vasodilator

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Inhaled NO Vasodilator Market Analysis and Forecast 2026-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchInhaled NO Vasodilator Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhaled NO Vasodilator Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Inhaled NO Vasodilator Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhaled NO Vasodilator Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhaled NO Vasodilator Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Inhaled NO Vasodilator market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Inhaled NO Vasodilator is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Inhaled NO Vasodilator is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Inhaled NO Vasodilator is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Inhaled NO Vasodilator is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Inhaled NO Vasodilator include Air Liquide, BOC Healthcare (Linde Group), Mallinckrodt and Praxair (Linde plc), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Inhaled NO Vasodilator, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Inhaled NO Vasodilator, also provides the sales of main regions and countries. Of the upcoming market potential for Inhaled NO Vasodilator, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Inhaled NO Vasodilator sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Inhaled NO Vasodilator market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Inhaled NO Vasodilator sales, projected growth trends, production technology, application and end-user industry.

Inhaled NO Vasodilator Segment by Company

Air Liquide

BOC Healthcare (Linde Group)

Mallinckrodt

Praxair (Linde plc)

Inhaled NO Vasodilator Segment by Type

800 ppm

100 ppm

Others

Inhaled NO Vasodilator Segment by Application

PPHN

ARDS

Others

Inhaled NO Vasodilator Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled NO Vasodilator market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaled NO Vasodilator and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled NO Vasodilator.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Inhaled NO Vasodilator in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Inhaled NO Vasodilator manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inhaled NO Vasodilator sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Inhaled NO Vasodilator Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 800 ppm Major Manufacturers Table 3. 100 ppm Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Inhaled NO Vasodilator Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. PPHN Major Manufacturers Table 7. ARDS Major Manufacturers Table 8. Others Major Manufacturers Table 9. Inhaled NO Vasodilator Industry Trends Table 10. Inhaled NO Vasodilator Industry Drivers Table 11. Inhaled NO Vasodilator Industry Opportunities and Challenges Table 12. Inhaled NO Vasodilator Industry Restraints Table 13. Global Inhaled NO Vasodilator Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Inhaled NO Vasodilator Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Inhaled NO Vasodilator Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Inhaled NO Vasodilator Revenue Market Share by Region (2021-2026) Table 17. Global Inhaled NO Vasodilator Revenue Market Share by Region (2027-2032) Table 18. Global Inhaled NO Vasodilator Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Inhaled NO Vasodilator Sales by Region (2021-2026) & (K Units) Table 20. Global Inhaled NO Vasodilator Sales by Region (2027-2032) & (K Units) Table 21. Global Inhaled NO Vasodilator Sales Market Share by Region (2021-2026) Table 22. Global Inhaled NO Vasodilator Sales Market Share by Region (2027-2032) Table 23. Global Inhaled NO Vasodilator Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Inhaled NO Vasodilator Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Inhaled NO Vasodilator Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Inhaled NO Vasodilator Sales Market Share by Manufacturers (2021-2026) Table 27. Global Inhaled NO Vasodilator Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Inhaled NO Vasodilator Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Inhaled NO Vasodilator Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Inhaled NO Vasodilator Manufacturers, Product Type & Application Table 31. Global Inhaled NO Vasodilator Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Inhaled NO Vasodilator by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Inhaled NO Vasodilator Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Inhaled NO Vasodilator Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Inhaled NO Vasodilator Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Inhaled NO Vasodilator Revenue Market Share by Type (2021-2026) Table 38. Global Inhaled NO Vasodilator Revenue Market Share by Type (2027-2032) Table 39. Global Inhaled NO Vasodilator Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Inhaled NO Vasodilator Sales by Type (2021-2026) & (K Units) Table 41. Global Inhaled NO Vasodilator Sales by Type (2027-2032) & (K Units) Table 42. Global Inhaled NO Vasodilator Sales Market Share by Type (2021-2026) Table 43. Global Inhaled NO Vasodilator Sales Market Share by Type (2027-2032) Table 44. Global Inhaled NO Vasodilator Price by Type (2021-2026) & (US$/Unit) Table 45. Global Inhaled NO Vasodilator Price by Type (2027-2032) & (US$/Unit) Table 46. Global Inhaled NO Vasodilator Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Inhaled NO Vasodilator Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Inhaled NO Vasodilator Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Inhaled NO Vasodilator Revenue Market Share by Application (2021-2026) Table 50. Global Inhaled NO Vasodilator Revenue Market Share by Application (2027-2032) Table 51. Global Inhaled NO Vasodilator Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Inhaled NO Vasodilator Sales by Application (2021-2026) & (K Units) Table 53. Global Inhaled NO Vasodilator Sales by Application (2027-2032) & (K Units) Table 54. Global Inhaled NO Vasodilator Sales Market Share by Application (2021-2026) Table 55. Global Inhaled NO Vasodilator Sales Market Share by Application (2027-2032) Table 56. Global Inhaled NO Vasodilator Price by Application (2021-2026) & (US$/Unit) Table 57. Global Inhaled NO Vasodilator Price by Application (2027-2032) & (US$/Unit) Table 58. Air Liquide Company Information Table 59. Air Liquide Business Overview Table 60. Air Liquide Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Air Liquide Inhaled NO Vasodilator Product Portfolio Table 62. Air Liquide Recent Development Table 63. BOC Healthcare (Linde Group) Company Information Table 64. BOC Healthcare (Linde Group) Business Overview Table 65. BOC Healthcare (Linde Group) Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. BOC Healthcare (Linde Group) Inhaled NO Vasodilator Product Portfolio Table 67. BOC Healthcare (Linde Group) Recent Development Table 68. Mallinckrodt Company Information Table 69. Mallinckrodt Business Overview Table 70. Mallinckrodt Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Mallinckrodt Inhaled NO Vasodilator Product Portfolio Table 72. Mallinckrodt Recent Development Table 73. Praxair (Linde plc) Company Information Table 74. Praxair (Linde plc) Business Overview Table 75. Praxair (Linde plc) Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Praxair (Linde plc) Inhaled NO Vasodilator Product Portfolio Table 77. Praxair (Linde plc) Recent Development Table 78. North America Inhaled NO Vasodilator Revenue by Type (2021-2026) & (US$ Million) Table 79. North America Inhaled NO Vasodilator Revenue by Type (2027-2032) & (US$ Million) Table 80. North America Inhaled NO Vasodilator Sales by Type (2021-2026) & (K Units) Table 81. North America Inhaled NO Vasodilator Sales by Type (2027-2032) & (K Units) Table 82. North America Inhaled NO Vasodilator Sales Price by Type (2021-2026) & (US$/Unit) Table 83. North America Inhaled NO Vasodilator Sales Price by Type (2027-2032) & (US$/Unit) Table 84. North America Inhaled NO Vasodilator Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Inhaled NO Vasodilator Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Inhaled NO Vasodilator Sales by Application (2021-2026) & (K Units) Table 87. North America Inhaled NO Vasodilator Sales by Application (2027-2032) & (K Units) Table 88. North America Inhaled NO Vasodilator Sales Price by Application (2021-2026) & (US$/Unit) Table 89. North America Inhaled NO Vasodilator Sales Price by Application (2027-2032) & (US$/Unit) Table 90. North America Inhaled NO Vasodilator Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Inhaled NO Vasodilator Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 92. North America Inhaled NO Vasodilator Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 93. North America Inhaled NO Vasodilator Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 94. North America Inhaled NO Vasodilator Sales by Country (2021-2026) & (K Units) Table 95. North America Inhaled NO Vasodilator Sales by Country (2027-2032) & (K Units) Table 96. North America Inhaled NO Vasodilator Sales Price by Country (2021-2026) & (US$/Unit) Table 97. North America Inhaled NO Vasodilator Sales Price by Country (2027-2032) & (US$/Unit) Table 98. United States Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 99. Canada Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 100. Europe Inhaled NO Vasodilator Revenue by Type (2021-2026) & (US$ Million) Table 101. Europe Inhaled NO Vasodilator Revenue by Type (2027-2032) & (US$ Million) Table 102. Europe Inhaled NO Vasodilator Sales by Type (2021-2026) & (K Units) Table 103. Europe Inhaled NO Vasodilator Sales by Type (2027-2032) & (K Units) Table 104. Europe Inhaled NO Vasodilator Sales Price by Type (2021-2026) & (US$/Unit) Table 105. Europe Inhaled NO Vasodilator Sales Price by Type (2027-2032) & (US$/Unit) Table 106. Europe Inhaled NO Vasodilator Revenue by Application (2021-2026) & (US$ Million) Table 107. Europe Inhaled NO Vasodilator Revenue by Application (2027-2032) & (US$ Million) Table 108. Europe Inhaled NO Vasodilator Sales by Application (2021-2026) & (K Units) Table 109. Europe Inhaled NO Vasodilator Sales by Application (2027-2032) & (K Units) Table 110. Europe Inhaled NO Vasodilator Sales Price by Application (2021-2026) & (US$/Unit) Table 111. Europe Inhaled NO Vasodilator Sales Price by Application (2027-2032) & (US$/Unit) Table 112. Europe Inhaled NO Vasodilator Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Inhaled NO Vasodilator Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 114. Europe Inhaled NO Vasodilator Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 115. Europe Inhaled NO Vasodilator Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 116. Europe Inhaled NO Vasodilator Sales by Country (2021-2026) & (K Units) Table 117. Europe Inhaled NO Vasodilator Sales by Country (2027-2032) & (K Units) Table 118. Europe Inhaled NO Vasodilator Sales Price by Country (2021-2026) & (US$/Unit) Table 119. Europe Inhaled NO Vasodilator Sales Price by Country (2027-2032) & (US$/Unit) Table 120. Germany Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 121. France Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 122. U.K. Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 123. Italy Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 124. Netherlands Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 125. Nordic Countries Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 126. China Inhaled NO Vasodilator Revenue by Type (2021-2026) & (US$ Million) Table 127. China Inhaled NO Vasodilator Revenue by Type (2027-2032) & (US$ Million) Table 128. China Inhaled NO Vasodilator Sales by Type (2021-2026) & (K Units) Table 129. China Inhaled NO Vasodilator Sales by Type (2027-2032) & (K Units) Table 130. China Inhaled NO Vasodilator Sales Price by Type (2021-2026) & (US$/Unit) Table 131. China Inhaled NO Vasodilator Sales Price by Type (2027-2032) & (US$/Unit) Table 132. China Inhaled NO Vasodilator Revenue by Application (2021-2026) & (US$ Million) Table 133. China Inhaled NO Vasodilator Revenue by Application (2027-2032) & (US$ Million) Table 134. China Inhaled NO Vasodilator Sales by Application (2021-2026) & (K Units) Table 135. China Inhaled NO Vasodilator Sales by Application (2027-2032) & (K Units) Table 136. China Inhaled NO Vasodilator Sales Price by Application (2021-2026) & (US$/Unit) Table 137. China Inhaled NO Vasodilator Sales Price by Application (2027-2032) & (US$/Unit) Table 138. Asia Inhaled NO Vasodilator Revenue by Type (2021-2026) & (US$ Million) Table 139. Asia Inhaled NO Vasodilator Revenue by Type (2027-2032) & (US$ Million) Table 140. Asia Inhaled NO Vasodilator Sales by Type (2021-2026) & (K Units) Table 141. Asia Inhaled NO Vasodilator Sales by Type (2027-2032) & (K Units) Table 142. Asia Inhaled NO Vasodilator Sales Price by Type (2021-2026) & (US$/Unit) Table 143. Asia Inhaled NO Vasodilator Sales Price by Type (2027-2032) & (US$/Unit) Table 144. Asia Inhaled NO Vasodilator Revenue by Application (2021-2026) & (US$ Million) Table 145. Asia Inhaled NO Vasodilator Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia Inhaled NO Vasodilator Sales by Application (2021-2026) & (K Units) Table 147. Asia Inhaled NO Vasodilator Sales by Application (2027-2032) & (K Units) Table 148. Asia Inhaled NO Vasodilator Sales Price by Application (2021-2026) & (US$/Unit) Table 149. Asia Inhaled NO Vasodilator Sales Price by Application (2027-2032) & (US$/Unit) Table 150. Asia Inhaled NO Vasodilator Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Asia Inhaled NO Vasodilator Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. Asia Inhaled NO Vasodilator Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. Asia Inhaled NO Vasodilator Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 154. Asia Inhaled NO Vasodilator Sales by Country (2021-2026) & (K Units) Table 155. Asia Inhaled NO Vasodilator Sales by Country (2027-2032) & (K Units) Table 156. Asia Inhaled NO Vasodilator Sales Price by Country (2021-2026) & (US$/Unit) Table 157. Asia Inhaled NO Vasodilator Sales Price by Country (2027-2032) & (US$/Unit) Table 158. Japan Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 159. South Korea Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 160. India Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 161. Australia Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 162. China Taiwan Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 163. Southeast Asia Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 164. SAMEA Inhaled NO Vasodilator Revenue by Type (2021-2026) & (US$ Million) Table 165. SAMEA Inhaled NO Vasodilator Revenue by Type (2027-2032) & (US$ Million) Table 166. SAMEA Inhaled NO Vasodilator Sales by Type (2021-2026) & (K Units) Table 167. SAMEA Inhaled NO Vasodilator Sales by Type (2027-2032) & (K Units) Table 168. SAMEA Inhaled NO Vasodilator Sales Price by Type (2021-2026) & (US$/Unit) Table 169. SAMEA Inhaled NO Vasodilator Sales Price by Type (2027-2032) & (US$/Unit) Table 170. SAMEA Inhaled NO Vasodilator Revenue by Application (2021-2026) & (US$ Million) Table 171. SAMEA Inhaled NO Vasodilator Revenue by Application (2027-2032) & (US$ Million) Table 172. SAMEA Inhaled NO Vasodilator Sales by Application (2021-2026) & (K Units) Table 173. SAMEA Inhaled NO Vasodilator Sales by Application (2027-2032) & (K Units) Table 174. SAMEA Inhaled NO Vasodilator Sales Price by Application (2021-2026) & (US$/Unit) Table 175. SAMEA Inhaled NO Vasodilator Sales Price by Application (2027-2032) & (US$/Unit) Table 176. SAMEA Inhaled NO Vasodilator Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. SAMEA Inhaled NO Vasodilator Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. SAMEA Inhaled NO Vasodilator Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. SAMEA Inhaled NO Vasodilator Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 180. SAMEA Inhaled NO Vasodilator Sales by Country (2021-2026) & (K Units) Table 181. SAMEA Inhaled NO Vasodilator Sales by Country (2027-2032) & (K Units) Table 182. SAMEA Inhaled NO Vasodilator Sales Price by Country (2021-2026) & (US$/Unit) Table 183. SAMEA Inhaled NO Vasodilator Sales Price by Country (2027-2032) & (US$/Unit) Table 184. Brazil Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 185. Argentina Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 186. Chile Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 187. Colombia Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 188. Peru Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 189. Saudi Arabia Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 190. Israel Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 191. UAE Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 192. Turkey Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 193. Iran Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 194. Egypt Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Table 195. Key Raw Materials Table 196. Raw Materials Key Suppliers Table 197. Inhaled NO Vasodilator Distributors List Table 198. Inhaled NO Vasodilator Customers List Table 199. Research Programs/Design for This Report Table 200. Authors List of This Report Table 201. Secondary Sources Table 202. Primary Sources List of Figures Figure 1. Inhaled NO Vasodilator Image Figure 2. Global Inhaled NO Vasodilator Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhaled NO Vasodilator Market Size Share 2021 VS 2025 VS 2032 Figure 4. 800 ppm Image Figure 5. 100 ppm Image Figure 6. Others Image Figure 7. Global Inhaled NO Vasodilator Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Inhaled NO Vasodilator Market Size Share 2021 VS 2025 VS 2032 Figure 9. PPHN Image Figure 10. ARDS Image Figure 11. Others Image Figure 12. Global Inhaled NO Vasodilator Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Figure 14. Global Inhaled NO Vasodilator Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Inhaled NO Vasodilator Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Inhaled NO Vasodilator Revenue Market Share by Region (2021-2032) Figure 17. Global Inhaled NO Vasodilator Sales (2021-2032) & (K Units) Figure 18. Global Inhaled NO Vasodilator Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Inhaled NO Vasodilator Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Inhaled NO Vasodilator Sales YoY (2021-2032) & (K Units) Figure 21. Europe Inhaled NO Vasodilator Sales YoY (2021-2032) & (K Units) Figure 22. China Inhaled NO Vasodilator Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Inhaled NO Vasodilator Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Inhaled NO Vasodilator Sales YoY (2021-2032) & (K Units) Figure 25. Global Inhaled NO Vasodilator Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Inhaled NO Vasodilator Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Inhaled NO Vasodilator Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Inhaled NO Vasodilator Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Inhaled NO Vasodilator Revenue Market Share by Type (2021-2032) Figure 31. Global Inhaled NO Vasodilator Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Inhaled NO Vasodilator Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Inhaled NO Vasodilator Sales Market Share by Type (2021-2032) Figure 34. Global Inhaled NO Vasodilator Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Inhaled NO Vasodilator Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Inhaled NO Vasodilator Revenue Market Share by Application (2021-2032) Figure 37. Global Inhaled NO Vasodilator Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Inhaled NO Vasodilator Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Inhaled NO Vasodilator Sales Market Share by Application (2021-2032) Figure 40. North America Inhaled NO Vasodilator Revenue Share by Type (2021-2032) Figure 41. North America Inhaled NO Vasodilator Sales Share by Type (2021-2032) Figure 42. North America Inhaled NO Vasodilator Revenue Share by Application (2021-2032) Figure 43. North America Inhaled NO Vasodilator Sales Share by Application (2021-2032) Figure 44. North America Inhaled NO Vasodilator Revenue Share by Country (2021-2032) Figure 45. North America Inhaled NO Vasodilator Sales Share by Country (2021-2032) Figure 46. Europe Inhaled NO Vasodilator Revenue Share by Type (2021-2032) Figure 47. Europe Inhaled NO Vasodilator Sales Share by Type (2021-2032) Figure 48. Europe Inhaled NO Vasodilator Revenue Share by Application (2021-2032) Figure 49. Europe Inhaled NO Vasodilator Sales Share by Application (2021-2032) Figure 50. Europe Inhaled NO Vasodilator Revenue Share by Country (2021-2032) Figure 51. Europe Inhaled NO Vasodilator Sales Share by Country (2021-2032) Figure 52. China Inhaled NO Vasodilator Revenue Share by Type (2021-2032) Figure 53. China Inhaled NO Vasodilator Sales Share by Type (2021-2032) Figure 54. China Inhaled NO Vasodilator Revenue Share by Application (2021-2032) Figure 55. China Inhaled NO Vasodilator Sales Share by Application (2021-2032) Figure 56. Asia Inhaled NO Vasodilator Revenue Share by Type (2021-2032) Figure 57. Asia Inhaled NO Vasodilator Sales Share by Type (2021-2032) Figure 58. Asia Inhaled NO Vasodilator Revenue Share by Application (2021-2032) Figure 59. Asia Inhaled NO Vasodilator Sales Share by Application (2021-2032) Figure 60. Asia Inhaled NO Vasodilator Revenue Share by Country (2021-2032) Figure 61. Asia Inhaled NO Vasodilator Sales Share by Country (2021-2032) Figure 62. SAMEA Inhaled NO Vasodilator Revenue Share by Type (2021-2032) Figure 63. SAMEA Inhaled NO Vasodilator Sales Share by Type (2021-2032) Figure 64. SAMEA Inhaled NO Vasodilator Revenue Share by Application (2021-2032) Figure 65. SAMEA Inhaled NO Vasodilator Sales Share by Application (2021-2032) Figure 66. SAMEA Inhaled NO Vasodilator Revenue Share by Country (2021-2032) Figure 67. SAMEA Inhaled NO Vasodilator Sales Share by Country (2021-2032) Figure 68. Inhaled NO Vasodilator Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Inhaled NO Vasodilator Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 800 ppm
  • 100 ppm
  • Others
Applications
  • PPHN
  • ARDS
  • Others
Companies covered
  • Air Liquide
  • BOC Healthcare (Linde Group)
  • Mallinckrodt
  • Praxair (Linde plc)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Inhaled NO Vasodilator Market by Type
  3. 1.2.1 Global Inhaled NO Vasodilator Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 800 ppm
  5. 1.2.3 100 ppm
  6. 1.2.4 Others
  7. 1.3 Inhaled NO Vasodilator Market by Application
  8. 1.3.1 Global Inhaled NO Vasodilator Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 PPHN
  10. 1.3.3 ARDS
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Inhaled NO Vasodilator Market Dynamics
  1. 2.1 Inhaled NO Vasodilator Industry Trends
  2. 2.2 Inhaled NO Vasodilator Industry Drivers
  3. 2.3 Inhaled NO Vasodilator Industry Opportunities and Challenges
  4. 2.4 Inhaled NO Vasodilator Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Inhaled NO Vasodilator Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Inhaled NO Vasodilator Revenue by Region
  3. 3.2.1 Global Inhaled NO Vasodilator Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Inhaled NO Vasodilator Revenue by Region (2021-2026)
  5. 3.2.3 Global Inhaled NO Vasodilator Revenue by Region (2027-2032)
  6. 3.2.4 Global Inhaled NO Vasodilator Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Inhaled NO Vasodilator Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Inhaled NO Vasodilator Sales by Region
  9. 3.4.1 Global Inhaled NO Vasodilator Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Inhaled NO Vasodilator Sales by Region (2021-2026)
  11. 3.4.3 Global Inhaled NO Vasodilator Sales by Region (2027-2032)
  12. 3.4.4 Global Inhaled NO Vasodilator Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Inhaled NO Vasodilator Revenue by Manufacturers
  2. 4.1.1 Global Inhaled NO Vasodilator Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Inhaled NO Vasodilator Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Inhaled NO Vasodilator Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Inhaled NO Vasodilator Sales by Manufacturers
  6. 4.2.1 Global Inhaled NO Vasodilator Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Inhaled NO Vasodilator Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Inhaled NO Vasodilator Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Inhaled NO Vasodilator Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Inhaled NO Vasodilator Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Inhaled NO Vasodilator Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Inhaled NO Vasodilator Manufacturers, Product Type & Application
  13. 4.7 Global Inhaled NO Vasodilator Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Inhaled NO Vasodilator Market CR5 and HHI
  16. 4.8.2 2025 Inhaled NO Vasodilator Tier 1, Tier 2, and Tier 3
5 Inhaled NO Vasodilator Market by Type
  1. 5.1 Global Inhaled NO Vasodilator Revenue by Type
  2. 5.1.1 Global Inhaled NO Vasodilator Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Inhaled NO Vasodilator Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Inhaled NO Vasodilator Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Inhaled NO Vasodilator Sales by Type
  6. 5.2.1 Global Inhaled NO Vasodilator Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inhaled NO Vasodilator Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Inhaled NO Vasodilator Sales Market Share by Type (2021-2032)
  9. 5.3 Global Inhaled NO Vasodilator Price by Type
6 Inhaled NO Vasodilator Market by Application
  1. 6.1 Global Inhaled NO Vasodilator Revenue by Application
  2. 6.1.1 Global Inhaled NO Vasodilator Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Inhaled NO Vasodilator Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Inhaled NO Vasodilator Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Inhaled NO Vasodilator Sales by Application
  6. 6.2.1 Global Inhaled NO Vasodilator Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Inhaled NO Vasodilator Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Inhaled NO Vasodilator Sales Market Share by Application (2021-2032)
  9. 6.3 Global Inhaled NO Vasodilator Price by Application
7 Company Profiles
  1. 7.1 Air Liquide
  2. 7.1.1 Air Liquide Company Information
  3. 7.1.2 Air Liquide Business Overview
  4. 7.1.3 Air Liquide Inhaled NO Vasodilator Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Air Liquide Inhaled NO Vasodilator Product Portfolio
  6. 7.1.5 Air Liquide Recent Developments
  7. 7.2 BOC Healthcare (Linde Group)
  8. 7.2.1 BOC Healthcare (Linde Group) Company Information
  9. 7.2.2 BOC Healthcare (Linde Group) Business Overview
  10. 7.2.3 BOC Healthcare (Linde Group) Inhaled NO Vasodilator Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 BOC Healthcare (Linde Group) Inhaled NO Vasodilator Product Portfolio
  12. 7.2.5 BOC Healthcare (Linde Group) Recent Developments
  13. 7.3 Mallinckrodt
  14. 7.3.1 Mallinckrodt Company Information
  15. 7.3.2 Mallinckrodt Business Overview
  16. 7.3.3 Mallinckrodt Inhaled NO Vasodilator Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mallinckrodt Inhaled NO Vasodilator Product Portfolio
  18. 7.3.5 Mallinckrodt Recent Developments
  19. 7.4 Praxair (Linde plc)
  20. 7.4.1 Praxair (Linde plc) Company Information
  21. 7.4.2 Praxair (Linde plc) Business Overview
  22. 7.4.3 Praxair (Linde plc) Inhaled NO Vasodilator Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Praxair (Linde plc) Inhaled NO Vasodilator Product Portfolio
  24. 7.4.5 Praxair (Linde plc) Recent Developments
8 North America
  1. 8.1 North America Inhaled NO Vasodilator Market Size by Type
  2. 8.1.1 North America Inhaled NO Vasodilator Revenue by Type (2021-2032)
  3. 8.1.2 North America Inhaled NO Vasodilator Sales by Type (2021-2032)
  4. 8.1.3 North America Inhaled NO Vasodilator Price by Type (2021-2032)
  5. 8.2 North America Inhaled NO Vasodilator Market Size by Application
  6. 8.2.1 North America Inhaled NO Vasodilator Revenue by Application (2021-2032)
  7. 8.2.2 North America Inhaled NO Vasodilator Sales by Application (2021-2032)
  8. 8.2.3 North America Inhaled NO Vasodilator Price by Application (2021-2032)
  9. 8.3 North America Inhaled NO Vasodilator Market Size by Country
  10. 8.3.1 North America Inhaled NO Vasodilator Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Inhaled NO Vasodilator Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Inhaled NO Vasodilator Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Inhaled NO Vasodilator Market Size by Type
  2. 9.1.1 Europe Inhaled NO Vasodilator Revenue by Type (2021-2032)
  3. 9.1.2 Europe Inhaled NO Vasodilator Sales by Type (2021-2032)
  4. 9.1.3 Europe Inhaled NO Vasodilator Price by Type (2021-2032)
  5. 9.2 Europe Inhaled NO Vasodilator Market Size by Application
  6. 9.2.1 Europe Inhaled NO Vasodilator Revenue by Application (2021-2032)
  7. 9.2.2 Europe Inhaled NO Vasodilator Sales by Application (2021-2032)
  8. 9.2.3 Europe Inhaled NO Vasodilator Price by Application (2021-2032)
  9. 9.3 Europe Inhaled NO Vasodilator Market Size by Country
  10. 9.3.1 Europe Inhaled NO Vasodilator Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Inhaled NO Vasodilator Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Inhaled NO Vasodilator Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Inhaled NO Vasodilator Market Size by Type
  2. 10.1.1 China Inhaled NO Vasodilator Revenue by Type (2021-2032)
  3. 10.1.2 China Inhaled NO Vasodilator Sales by Type (2021-2032)
  4. 10.1.3 China Inhaled NO Vasodilator Price by Type (2021-2032)
  5. 10.2 China Inhaled NO Vasodilator Market Size by Application
  6. 10.2.1 China Inhaled NO Vasodilator Revenue by Application (2021-2032)
  7. 10.2.2 China Inhaled NO Vasodilator Sales by Application (2021-2032)
  8. 10.2.3 China Inhaled NO Vasodilator Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Inhaled NO Vasodilator Market Size by Type
  2. 11.1.1 Asia Inhaled NO Vasodilator Revenue by Type (2021-2032)
  3. 11.1.2 Asia Inhaled NO Vasodilator Sales by Type (2021-2032)
  4. 11.1.3 Asia Inhaled NO Vasodilator Price by Type (2021-2032)
  5. 11.2 Asia Inhaled NO Vasodilator Market Size by Application
  6. 11.2.1 Asia Inhaled NO Vasodilator Revenue by Application (2021-2032)
  7. 11.2.2 Asia Inhaled NO Vasodilator Sales by Application (2021-2032)
  8. 11.2.3 Asia Inhaled NO Vasodilator Price by Application (2021-2032)
  9. 11.3 Asia Inhaled NO Vasodilator Market Size by Country
  10. 11.3.1 Asia Inhaled NO Vasodilator Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Inhaled NO Vasodilator Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Inhaled NO Vasodilator Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Inhaled NO Vasodilator Market Size by Type
  2. 12.1.1 SAMEA Inhaled NO Vasodilator Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Inhaled NO Vasodilator Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Inhaled NO Vasodilator Price by Type (2021-2032)
  5. 12.2 SAMEA Inhaled NO Vasodilator Market Size by Application
  6. 12.2.1 SAMEA Inhaled NO Vasodilator Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Inhaled NO Vasodilator Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Inhaled NO Vasodilator Price by Application (2021-2032)
  9. 12.3 SAMEA Inhaled NO Vasodilator Market Size by Country
  10. 12.3.1 SAMEA Inhaled NO Vasodilator Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Inhaled NO Vasodilator Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Inhaled NO Vasodilator Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Inhaled NO Vasodilator Value Chain Analysis
  2. 13.1.1 Inhaled NO Vasodilator Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Inhaled NO Vasodilator Production Mode & Process
  6. 13.2 Inhaled NO Vasodilator Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Inhaled NO Vasodilator Distributors
  9. 13.2.3 Inhaled NO Vasodilator Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst